During the past decade, Instituto Del Buen Aire conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto Del Buen Aire" are "Acute Respiratory Infection" (1 trials), "Asthma" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials) and "Influenza A" (1 trials). Many other conditions were trialed in "Instituto Del Buen Aire" in a lesser frequency.

Most popular intervention types in "Instituto Del Buen Aire" are "Drug" (4 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Lebrikizumab" (2 trials), "HZN-825" (1 trials), "Nasal Swab Sample" (1 trials) and "Pimodivir 600 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Del Buen Aire" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Del Buen Aire". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Instituto Del Buen Aire, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Del Buen Aire, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".